Tokyo, May 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061320) titled 'Real-World Comparison of Tirzepatide and Semaglutide in Patients with Type 2 Diabetes' on May 1.
Study Type:
Observational
Primary Sponsor:
Institute - Kimitsu Chuo Hospital
Condition:
Condition - Type 2 diabetes mellitus
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The aim of this study is to compare the effects of semaglutide and tirzepatide on eating behavior and treatment satisfaction among patients with type 2 diabetes in real-world clinical practice in Japan using existing treatment cohorts.
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 18
ye...